Home > Cancer and Treatments > Endocrine Cancers

Endocrine Oncology Program Research

Gary Hammer, M.D., Ph.D., director

The Endocrine Oncology Program is a multidisciplinary clinical and research program focused on the genetics, endocrine cancer stem cells, pathogenesis (the process/stages of disease development) and treatment of endocrine cancers. Two multidisciplinary clinics specialize in the treatment of thyroid and adrenal tumors, respectively. Active laboratory programs include work in the areas of adrenal and thyroid cancer genetics, gene discovery, adrenal cancer metastasis, adrenal and thyroid carcinogenesis (cancer causing agents), and adrenal and thyroid cell biology. Recently, research has expanded broadly into the use of gene expression profiles as diagnostic and prognostic indicators. Endocrine Oncology Program investigators participate in a number of therapeutic trials for advanced thyroid and adrenocortical carcinoma. Biological based therapies are currently under pre-clinical and clinical development for adrenal cancer. The U-M Comprehensive Cancer Center is one of only a few centers in the country with a focused endocrine oncology program and embedded thyroid and adrenal clinics.

Continue Reading about the endocrine oncology research:

Adrenal Cancer Genetics
Research on the genetics of adrenal cancer

The Michigan Endocrine Database (MED)
The MED is a secure database of clinical information regarding clinical characteristics of adrenal cancer patients treated at University of Michigan.

The Michigan Endocrine Tissue Bank (METB).

Clinical Trials

Research Faculty

Adjust text size